References
- Reid J, Taylor TV, Holt S, et al. Benign gastric ulceration in pernicious anemia. Dig Dis Sci 1980; 25(2): 148–9
- Goldschmiedt M, Peterson WL, Vuitch F, et al. Postbulbar duodenal ulcer in a patient with pentagastrin-fast achlorhydria. Gastroenterology 1989; 97(3): 771–4
- Feldman M, Richardson CT. Total 24-hour gastric acid secretion in patients with duodenal ulcer: comparison with normal subjects and effects of Cimetidine and parietal cell vagotomy. Gastroenterology 1986; 90(3): 540–4
- Savarino V, Mela GS, Scalabrini P, et al. 24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry. Dig Dis Sci 1988; 33(9): 1077–80
- Merki HS, Fimmel CJ, Wait RP, et al. Pattern of 24 hour intragastric acidity in active duodenal ulcer disease and in healthy controls. Gut 1988; 29(11): 1583–7
- Soll AH. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. 5th ed. Philadelphia: WB Saunders, 1993; 591
- Graham DY, Opelsun A, Lew GM, et al. Aberration of exaggerated meal-stimulated gastrum release in duodenal ulcer patients after clearance of Helicobacter pylori infection. Am J Gastroenterol 1990; 85(4): 394–8
- Ulcer disease: investigation and basis for therapy. In: Swabb EA, Szabo S, eds. Clinical pharmacology. New York: Dekker, 1991
- Feldman M, Burton ME. Histamine 2- receptor antagonists— standard therapy for acid-peptic disease (first of two parts). N Engl J Med 1990; 323(24): 1672–80
- Tosi S, Cagnoli M. Painful gynecomastia with ranitidine. (Letter) Lancet 1982; 2(8290): 160
- Kassianos GC. Impotence and nizatidine. (Letter) Lancet 1989; 1(8644): 963
- Cantu TG, Korek JS. Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med 1991; 114(12): 1027–34
- Swabb, Szabo, eds8,” pp 217–8
- Jochem V, Kirkpatrick R, Greenson J, et al. Fulminant hepatic failure related to omeprazole. Am J Gastroenterol 1992; 87(4): 523–5
- Carlsson E. A review of the effects of long-term acid inhibition in animals. Scand J Gastroenterol (Suppl) 1989; 166: 19–23
- Ryberg B, Tielemans Y, Axelson J, et al. Gastrin stimulates the self-replication rate of en-terochromaffinlike cells in the tat stomach: effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology 1990; 99(4): 935–42
- Brunner G, Creutzfeldt W, Harke U, et al. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion 1988; 39(2): 80–90
- Jansen JB, Klinkenberg-Knol EC, Meuwissen SG, et al. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 1990; 99(3): 621–8
- Andersson T. Omeprazole drug interaction studies. Clin Pharmacokinet 1991; 21(3): 195–212
- Mulder CJ, Schipper DL. Omeprazole and ranitidine in duodenal ulcer healing: analysis of comparative clinical trials. Scand J Gastroenterol (Suppl) 1990; 178: 62–6
- Poynard T, Pignon JP. Acute treatment of duodenal ulcer. In: Poynard T, Pignon JR eds. Duodenal ulcer: analysis of 293 randomized clinical trials. London: John Libbey Eurotext, 1989
- Valenzuela JE, Berlin RG, Snape WJ, et al, for the Omeprazole DU Comparative Study Group. U.S. experience with omeprazole in duodenal ulcer: multicenter double-blind comparative study with ranitidine. Dig Dis Sci 1991; 36(6): 761–8
- Bardhan KD, Naesdal J, Bianchi Porro G, et al. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial. Gut 1991; 32(4): 435–8
- Kowdley KV, Cheriyan A, McCullough AJ. Healing ulcers with H2 blockers or omeprazole? Practical Gastroenterol (Suppl) 1993; 27(12): 33–9
- Sontag SJ. Strategies to maintain ulcers in remission. Practical Gastroenterol (Suppl) 1993; 27(12): 16–22